The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn.
作者信息
Reiffel James A
机构信息
Professor of Clinical Medicine, Columbia University.
出版信息
J Atr Fibrillation. 2010 Oct 22;3(3):304. doi: 10.4022/jafib.304. eCollection 2010 Oct-Nov.
Abstract
摘要
相似文献
1
The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn.
J Atr Fibrillation. 2010 Oct 22;3(3):304. doi: 10.4022/jafib.304. eCollection 2010 Oct-Nov.
2
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.
J Mol Cell Cardiol. 2016 May;94:95-106. doi: 10.1016/j.yjmcc.2016.03.012. Epub 2016 Apr 4.
3
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
Pol Merkur Lekarski. 2016 Dec 22;41(246):287-292.
4
Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.
Front Pharmacol. 2019 Nov 26;10:1367. doi: 10.3389/fphar.2019.01367. eCollection 2019.
5
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
J Cardiovasc Electrophysiol. 2009 Jul;20(7):796-802. doi: 10.1111/j.1540-8167.2009.01437.x. Epub 2009 Feb 27.
6
Ranolazine Therapy in Cardiac Arrhythmias.
Pacing Clin Electrophysiol. 2016 Sep;39(9):1006-15. doi: 10.1111/pace.12905. Epub 2016 Jul 23.
7
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Cardiovasc Ther. 2013 Dec;31(6):e63-71. doi: 10.1111/1755-5922.12035.
8
Comparison of vernakalant and ranolazine in atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2017 Sep;18(9):663-668. doi: 10.2459/JCM.0000000000000545.
9
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.
10
Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):254-9. doi: 10.2459/JCM.0b013e328365b554.
引用本文的文献
1
Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?
J Atr Fibrillation. 2013 Apr 6;5(6):752. doi: 10.4022/jafib.752. eCollection 2013 Apr-May.
2
The Use of Ranolazine in the Management of Recurrent Atrial Fibrillation After Percutaneous Radiofrequency Ablation.
J Atr Fibrillation. 2012 Aug 20;5(2):562. doi: 10.4022/jafib.562. eCollection 2012 Aug-Sep.
本文引用的文献
1
Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?
J Atr Fibrillation. 2008 May 16;1(1):21. doi: 10.4022/jafib.21. eCollection 2008 May-Jun.
2
The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.
Indian Pacing Electrophysiol J. 2009 Sep 1;9(5):260-7.
3
Effect of dronedarone on cardiovascular events in atrial fibrillation.
N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778.
4
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation.
Indian Pacing Electrophysiol J. 2008 Aug 1;8(3):175-81.
5
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation. 2007 Oct 9;116(15):1647-52. doi: 10.1161/CIRCULATIONAHA.107.724880. Epub 2007 Sep 5.
6
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
Circulation. 2007 Sep 25;116(13):1449-57. doi: 10.1161/CIRCULATIONAHA.107.704890. Epub 2007 Sep 4.
7
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
JAMA. 2007 Apr 25;297(16):1775-83. doi: 10.1001/jama.297.16.1775.
8
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
Eur Heart J. 2006 Aug;27(16):1979-2030. doi: 10.1093/eurheartj/ehl176.
9
Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1(Suppl 1):S169-S177. doi: 10.1111/j.1540-8167.2006.00401.x.
10
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
Circulation. 2004 Aug 24;110(8):904-10. doi: 10.1161/01.CIR.0000139333.83620.5D. Epub 2004 Aug 9.
Zotero 插件